Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 6-PM Johnson says UK in 'race against time' as it faces worst weeks of pandemic

Mon, 11th Jan 2021 07:42

* "Very perilous moment", Johnson says

* Hospitals running out of oxygen

* Dangerous time ahead for health service - medical adviser

* UK has vaccinated 2 million so far

* People must stick to lockdown rules, Johnson says
(Adds UK vaccination plan)

By Michael Holden

LONDON, Jan 11 (Reuters) - Prime Minister Boris Johnson said
on Monday Britain was in "a race against time" to rollout
COVID-19 vaccines as deaths hit record highs and hospitals run
out of oxygen, with his top medical adviser saying the
pandemic's worst weeks were imminent.

A new, more transmissible variant of the disease is now
surging through the population, with one in 20 people in parts
of London now infected, threatening to overwhelm the health
service with hospitals overloaded with patients.

The death toll in the United Kingdom has been soaring and
now stands in excess of 81,000 - the world's fifth-highest toll
- while more than 3 million people have tested positive.

In a bid to get on top of the pandemic and to try to restore
some degree of normality by the spring, Britain is rushing out
its largest ever vaccination programme, with shots to be offered
to about 15 million people by the middle of next month.

"It's a race against time, because we can all see the threat
that our NHS faces, the pressure it's under, the demand in
intensive care units, the pressure on ventilated beds, even the
shortage of oxygen in some places," Johnson said on a visit to a
vaccination centre in Bristol, in southwest England.

"This is a very perilous moment. The worst thing now for us
is to allow success in rolling out a vaccine programme to breed
any kind of complacency about the state of the pandemic."

The government's chief medical adviser Chris Whitty had
earlier warned the situation was set to deteriorate.

"The next few weeks are going to be the worst weeks of this
pandemic in terms of numbers into the NHS (National Health
Service)," he told BBC TV.

"Anybody who is not shocked by the number of people in
hospital who are seriously ill at the moment and who are dying
over the course of this pandemic, I think, has not understood
this at all. This is an appalling situation," he told BBC TV.

"DANGEROUS TIME"

During the peak of the first outbreak in April, about 18,000
people were in hospital but now there are 30,000, Whitty said,
describing it as "the most dangerous time we've really had in
terms of numbers".

Johnson's government is pinning its hopes on a mass
vaccination programme after Britain became the first country to
approve vaccines developed by Oxford-AstraZeneca and by
Pfizer/BioNTech , and approved Moderna's
shot on Friday.

Its plan, announced on Monday, envisages 2 million shots
being delivered at some 2,700 centres a week in England by the
end of January, with the aim of immunising tens of millions of
people by the spring and all adults offered a vaccine by the
autumn.

Johnson said 2 million people had already been given the
vaccine - more than any other European country - but admitted
that inoculating 15 million people in the four highest risk
levels, including those over 70 and frontline health workers, by
a Feb. 15 target was "a huge ask".

"We believe it's achievable, we're going throw absolutely
everything at it, to get it done," he said.

Opposition Labour leader Keir Starmer, who has repeatedly
accused Johnson of being too slow to respond to the pandemic,
said the prime minister's indecision had cost lives and worsened
the economic impact

"We shouldn’t be facing the slowest recovery and we
shouldn’t be suffering the tragedy of so many deaths every day
from this virus," he said.

Ministers and health chiefs have pleaded with people to
respect lockdown measures and stay at home, amid fears some
people are not adhering to the rules strictly enough, along with
concern that the virus is being spread in supermarkets.

"Where we have to tighten them, we will," Johnson said of
the rules.
(Additional reporting by Guy Faulconbridge, Kate Holton,
William Schomberg, Paul Sandle and James Davey; writing by
Michael Holden; editing by Estelle Shirbon, Guy Faulconbridge
and Angus MacSwan)

More News
Today 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
Today 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.